Portfolio company
Bionode
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops wearable neuro-modulation devices and gold-trace contact lenses to treat and prevent elevated intraocular pressure in patients with glaucoma.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Glakolens
This company develops sensor-embedded contact lenses that provide continuous intraocular pressure monitoring for patients with glaucoma and ocular hypertension.
Azalea Vision
This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.
Rheon Medical SA
This company develops adjustable drainage devices and ocular implants for the surgical treatment of glaucoma in patients.
G-Metrics
This digital health company develops implantable micro-sensors and monitoring platforms for glaucoma patients and ophthalmologists to manage intraocular pressure.
Tavo Biotherapeutics
The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.
Neuro Modulation Artificial Retina
This company develops a high-acuity spherical bionic retinal implant to restore vision for patients with retinitis pigmentosa or age-related macular degeneration.
Biophta
This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
